SCHEMBL34473284

SCHEMBL34473284

[N-]=[N+]=NCC(=O)c1ccc(N)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ CYP19A1 P11511 1/20 0.38
▸ LMNA P02545 3/20 0.38
▸ MAPT P10636 2/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ MAOA P21397 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ SLC22A6 Q4U2R8 1/20 0.37
▸ SLC22A8 Q8TCC7 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ APEX1 P27695 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ CA2 P00918 1/20 0.35
▸ CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28984896 0.83 GSK3B (0.52) MEN1KMT2ALMNAMAPTRAB9A
SCHEMBL28214996 0.83 NPC1 (0.48) LMNAMAPTRAB9ANPC1KDM4E
SCHEMBL13857466 0.81 GSK3B (0.55) MEN1KMT2ALMNARAB9ANPC1
SCHEMBL14466949 0.81 GSK3B (0.52) KMT2ALMNAMAPTRAB9ANPC1
SCHEMBL13817452 0.81 NPC1 (0.50) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL13525672 0.81 KMT2A (0.50) MEN1KMT2ALMNAMAPTCYP1A2
SCHEMBL16322250 0.78 ALDH1A1 (0.47) MEN1KMT2ALMNAMAPTCYP1A2
SCHEMBL14033521 0.77 GSK3B (0.54) MEN1KMT2AMAPTRAB9APOLB
SCHEMBL22925495 0.77 PTPN1 (0.54) MAPTGSK3B
SCHEMBL14922097 0.77 HDAC3 (0.59) LMNAMAPTRAB9ANPC1APEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026090173-A1 MODIFIED SELF-IMMOLATING MOIETIES IN ANTIBODY-DRUG CONJUGATES CODEABLE THERAPEUTICS, INCORPORATED (US) 2026-04-30 — — WO disclosed
Send feedback